Intra-Arterial Infusion Chemotherapy Using Cisplatin With Radiotherapy for Stage III Squamous Cell Carcinoma of the Cervix
β Scribed by Yuko Kaneyasu; Nobutaka Nagai; Yasushi Nagata; Yasutoshi Hashimoto; Shintaro Yuki; Yuji Murakami; Masahiro Kenjo; Hideaki Kakizawa; Naoyuki Toyota; Hisaya Fujiwara; Yoshiki Kudo; Katsuhide Ito
- Book ID
- 108148801
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 276 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Twelve patients with advanced locoregional (Stage III and IV) squamous cell carcinoma of the oral cavity and oropharynx underwent treatment with cisplatin, vinblastine, bleomycin, and 5-fluorouracil, given by intra-arterial infusion, as primary adjuvant therapy, in preparation for radiation therapy
## Abstract ## Background This study was established to determine the maximum tolerated dose of intraβarterial cisplatin (IAC) concurrent with accelerated fractionation radiotherapy for locally advanced head and neck squamous cell carcinoma (HNSCC). ## Methods We conducted a phase I study. Treat
## Abstract Combined simultaneous radiotherapy and multidrug chemotherapy have been utilized in an attempt to eradicate or shrink tumors of the head and neck area in advanced stages to allow subsequent surgical extirpation. Thirtyβsix patients (1 stage II; 11 stage III; 24 stage IV; 1 unknown prima
## Abstract The combination of cisplatin and cytosine arabinoside has been shown in experimental models to be synergistic. We conducted a pilot study of cytosine arabinoside and cisplatin in unresectable or metastatic cancer of the esophagus in five patients and found significant activity, also on